Quris-AI
Click to visit website
About
Quris is a groundbreaking AI innovator reshaping drug development through its Bio-AI Clinical Prediction Platform, which effectively predicts drug candidates' safety for humans, addressing the significant costs associated with failed clinical trials. The platform employs a unique machine-learning approach using data from miniaturized 'Patients-on-a-Chip', allowing for effective training of classification algorithms. Led by a distinguished team from Boston and Tel-Aviv, including notable figures like Moderna co-founder Robert Langer and Nobel Laureate Aaron Ciechanover, Quris is poised to transform the pharmaceutical landscape by focusing on predicting safe drug candidates, which presents a trillion-dollar challenge in the industry. Quris commits to innovation while emphasizing positive impact and robust ESG standards.
Platform
Task
Features
• commits to positive impact and esg standards
• focuses on reducing costs associated with failed clinical trials
• developed by a team of leading scientists and investors
• utilizes machine-learning trained on patients-on-a-chip
• predicts drug safety in humans
Average Rating: 0.0
Average Rating: 0.0
5 Stars:
0 Ratings
4 Stars:
0 Ratings
3 Stars:
0 Ratings
2 Stars:
0 Ratings
1 Star:
0 Ratings
User Ratings
No ratings available.
Sign In to Rate this Tool
Featured Tools
Scalytics Connect
A federated AI framework that integrates decentralized data sources for AI development.
View Details
WhyHow.AI
Transform unstructured data into structured knowledge for accurate AI solutions.
View Details